ATG7 Human shRNA Plasmid Kit (Locus ID 10533)
CAT#: TR314609
ATG7 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | ATG7 Human shRNA Plasmid Kit (Locus ID 10533) |
Locus ID | 10533 |
UniProt ID | O95352 |
Synonyms | APG7-LIKE; APG7L; GSA7 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | ATG7 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 10533). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001136031, NM_001144912, NM_006395, NM_001349232, NM_001349233, NM_001349234, NM_001349235, NM_001349236, NM_001349237, NM_001349238, NM_006395.1, NM_006395.2, NM_001144912.1, NM_001136031.1, NM_001136031.2, BC000091, NM_001136031.3, NM_001144912.2, NM_006395.3 |
Summary | This gene encodes an E1-like activating enzyme that is essential for autophagy and cytoplasmic to vacuole transport. The encoded protein is also thought to modulate p53-dependent cell cycle pathways during prolonged metabolic stress. It has been associated with multiple functions, including axon membrane trafficking, axonal homeostasis, mitophagy, adipose differentiation, and hematopoietic stem cell maintenance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
ATGs ubiquitination is required for circumsporozoite protein to subvert host innate immunity against malaria liver stage
,Zheng, H;Lu, X;Li, K;Zhu, F;Zhao, C;Liu, T;Ding, Y;Fu, Y;Zhang, K;Zhou, T;Dai, J;Wu, Y;Xu, W;,
bioRxiv
[ATG7]
|
Energy Restriction as an Antitumor Target of Thiazolidinediones
,Shuo Wei, Samuel K. Kulp, and Ching-Shih Chen,
J. Biol. Chem., Mar 2010; 285: 9780 - 9791
[ATG7]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...